Concepedia

Publication | Open Access

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

DOIFull Paper Access

50

Citations

24

References

2021

Year

Julia Maria Ressler, Matthias Karasek, Lukas Koch, Rita Silmbrod, Joanna Mangana, Sofiya Latifyan, Veronica Aedo-Lopez, Helmut Kehrer, Felix Weihsengruber, Peter Koelblinger,
Journal for ImmunoTherapy of Cancer

Abstract

This real-life cohort treatment with T-VEC showed a high ORR and a large number of durable CRs.

References

YearCitations

Page 1